ABSENCE OF A CLINICALLY SIGNIFICANT PHARMACOKINETIC INTERACTION BETWEEN TELMISARTAN AND ROSUVASTATIN, AND DEVELOPMENT OF A BIOEQUIVALENT FIXED-DOSE COMBINATION

作者:Son M; Kim Y; Chae D; Lee D; Gug J; Jang S; Seo J; Park Y; Nam S; Kim M; Park K
来源:Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT), 2014-03-18 to 2014-03-22.
  • 出版日期2014-3